N. Thompson

767 total citations
18 papers, 672 citations indexed

About

N. Thompson is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, N. Thompson has authored 18 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Immunology. Recurrent topics in N. Thompson's work include Protein Kinase Regulation and GTPase Signaling (5 papers), Nitric Oxide and Endothelin Effects (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). N. Thompson is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), Nitric Oxide and Endothelin Effects (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). N. Thompson collaborates with scholars based in United Kingdom. N. Thompson's co-authors include Robert W. Bonser, L.G. Garland, Roger Randall, Graham D. Spacey, M.C. Scrutton, H. F. Hodson, J.E. Tateson, Iain Uings, Alan T. Hudson and Robert B. Wallis and has published in prestigious journals such as The Journal of Immunology, Biochemical Journal and FEBS Letters.

In The Last Decade

N. Thompson

18 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Thompson United Kingdom 10 442 209 176 68 51 18 672
J. Wadsworth United Kingdom 11 552 1.2× 121 0.6× 138 0.8× 57 0.8× 44 0.9× 20 935
Kelly Gray United Kingdom 12 468 1.1× 249 1.2× 236 1.3× 61 0.9× 57 1.1× 16 1.0k
John A. Mitchell United States 10 404 0.9× 119 0.6× 119 0.7× 30 0.4× 37 0.7× 18 777
William M. Scribner United States 14 425 1.0× 176 0.8× 211 1.2× 110 1.6× 29 0.6× 16 718
C. Miller United States 10 511 1.2× 82 0.4× 194 1.1× 54 0.8× 69 1.4× 14 1.2k
Tiffany L. Thai United States 18 639 1.4× 211 1.0× 82 0.5× 63 0.9× 87 1.7× 24 893
Wenyi Che United States 15 629 1.4× 153 0.7× 80 0.5× 54 0.8× 32 0.6× 16 902
Francine Cand France 10 347 0.8× 68 0.3× 117 0.7× 85 1.3× 27 0.5× 16 609
J H Gronich United States 7 490 1.1× 67 0.3× 144 0.8× 83 1.2× 25 0.5× 7 723
Suryanarayana Vepa United States 13 394 0.9× 180 0.9× 212 1.2× 102 1.5× 42 0.8× 14 676

Countries citing papers authored by N. Thompson

Since Specialization
Citations

This map shows the geographic impact of N. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Thompson more than expected).

Fields of papers citing papers by N. Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Thompson. The network helps show where N. Thompson may publish in the future.

Co-authorship network of co-authors of N. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of N. Thompson. A scholar is included among the top collaborators of N. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Thompson. N. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ward, George A., Gianni Chessari, Christopher N. Johnson, et al.. (2014). 380 Induction of apoptosis with a novel dual cIAP1/XIAP antagonist in models of melanoma. European Journal of Cancer. 50. 122–122. 2 indexed citations
2.
Courtin, Aurélie, et al.. (2014). 518 The HSP90 inhibitor, AT13387, overcomes resistance to crizotinib and second generation ALK inhibitors. European Journal of Cancer. 50. 168–168. 2 indexed citations
3.
Thompson, N., Mok‐Ryeon Ahn, Gianni Chessari, et al.. (2012). 85 Characterization of a Potent XIAP and CIAP1 Dual Antagonist in Models of Melanoma and Leukemia. European Journal of Cancer. 48. 27–27. 3 indexed citations
4.
Lyons, John, Joseph Curry, Matthias Reule, et al.. (2008). 147 POSTER AT13387, a fragment derived clinical candidate is active in lung and melanoma models. European Journal of Cancer Supplements. 6(12). 47–47. 2 indexed citations
5.
Garrett, Michelle D., John Caldwell, M.G. Rowlands, et al.. (2004). 322 Novel isoquinoline-5-sulfonamides as biochemical and cellular inhibitors of PKB/AKt. European Journal of Cancer Supplements. 2(8). 98–98. 3 indexed citations
6.
Hall, Simon R., et al.. (1997). Convergence of Schiff base costimulatory signaling and TCR signaling at the level of mitogen-activated protein kinase ERK2. The Journal of Immunology. 159(5). 2274–2281. 17 indexed citations
7.
Uings, Iain, N. Thompson, Roger Randall, et al.. (1992). Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil. Biochemical Journal. 281(3). 597–600. 133 indexed citations
8.
Bonser, Robert W., N. Thompson, Roger Randall, et al.. (1991). Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil. British Journal of Pharmacology. 103(1). 1237–1241. 106 indexed citations
9.
Thompson, N., J.E. Tateson, Roger Randall, et al.. (1990). The temporal relationship between phospholipase activation, diradylglycerol formation and superoxide production in the human neutrophil. Biochemical Journal. 271(1). 209–213. 41 indexed citations
10.
Bonser, Robert W., N. Thompson, Roger Randall, & L.G. Garland. (1989). Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil. Biochemical Journal. 264(2). 617–620. 187 indexed citations
11.
Thompson, N., Robert W. Bonser, H. F. Hodson, & L.G. Garland. (1988). Ca2+-independent binding of [3H]phorbol dibutyrate to protein kinase C is supported by protamine and other polycations. Biochemical Journal. 255(2). 417–422. 9 indexed citations
12.
Garland, L.G., Robert W. Bonser, & N. Thompson. (1987). Protein kinase C inhibitors are not selective. Trends in Pharmacological Sciences. 8(9). 334–334. 47 indexed citations
13.
Dawson, John A., N. Thompson, Robert W. Bonser, H. F. Hodson, & L.G. Garland. (1987). Decrease of cellular ATP by dihexanoylglycerol may limit responses to protein kinase C activation. FEBS Letters. 214(1). 171–175. 7 indexed citations
14.
Dawson, John A., Robert W. Bonser, N. Thompson, et al.. (1986). Differential inhibition by 1-oleoyl-2-acetyl-sn-glycerol of responses to phorbol dibutyrate or phorbol myristate acetate. Biochemical Society Transactions. 14(6). 1154–1155. 1 indexed citations
15.
Bonser, Robert W., John A. Dawson, N. Thompson, H. F. Hodson, & L.G. Garland. (1986). Inhibition of phorbol ester stimulated superoxide production by 1‐oleoyl‐2‐acetyl‐sn‐glycerol (OAG); fact or artefact?. FEBS Letters. 209(1). 134–138. 14 indexed citations
16.
Thompson, N., M.C. Scrutton, & Robert B. Wallis. (1986). Particle volume changes associated with light transmittance changes in the platelet aggregometer: Dependence upon aggregating agent and effectiveness of stimulus. Thrombosis Research. 41(5). 615–626. 41 indexed citations
17.
Thompson, N., et al.. (1985). The use of the platelet aggregometer to monitor thrombin-induced conversion of fibrinogen to fibrin. Thrombosis Research. 40(5). 703–709. 5 indexed citations
18.
Hallam, Trevor J., N. Thompson, M.C. Scrutton, & T J Rink. (1984). The role of cytoplasmic free calcium in the responses of quin2-loaded human platelets to vasopressin. Biochemical Journal. 221(3). 897–901. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Wadsworth Breakdown of academic impact, for papers by Kelly Gray Breakdown of academic impact, for papers by John A. Mitchell Breakdown of academic impact, for papers by William M. Scribner Breakdown of academic impact, for papers by C. Miller Breakdown of academic impact, for papers by Tiffany L. Thai Breakdown of academic impact, for papers by Wenyi Che Breakdown of academic impact, for papers by Francine Cand Breakdown of academic impact, for papers by J H Gronich Breakdown of academic impact, for papers by Suryanarayana Vepa
Rankless by CCL
2026